⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockFranceNasdaqGS

SNY

Sanofi

Healthcare · Drug Manufacturers - General

41.60USD

-0.3600 (-0.86%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on SNY.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(EUR)
1)

Issue Data

Last PxUSD / 41.60
P/E25.2
Dvd Ind Yld5.8%
P/B1.44
P/S2.0
Curr EV/T12M EBITDA—
Mkt Cap (USD)99.7B
Curr EV (USD)—
2)

Per Share Data

EPS T12M1.63
DPS1.99
Bk Val Per Sh32.45
Rev/Sh20.44
Cash/Sh2.65
Curr Shares Out2,396.1M
FCF/Sh2.93
3)

Cash Flow Analysis

P/CF8.4
Curr P/FCF14.2
CF/NI3.0
Dvd P/O120.6%
Cash Gen/Cash Reqd1.4
Csh Dvd Cov2.5
CFO/Sales24.2%
Eff Interest Rate3.5%
4)

Growth Potential

Dil EPS 1Y Gr38.8%
Cap 1Y Gr-3.8%
BPS 1Y Gr-6.0%
R&D To Sales16.6%
Retention Rate-20.6%
Rev 1Y Gr5.5%
FCF 1Y Gr22.5%
Assets 1Y Gr-4.5%
5)

Profitability

EBITDA15.3B
EBIT10.1B
Operating Margin20.6%
Pretax Margin11.1%
Net Margin8.1%
ROA3.1%
ROE5.7%
ROC8.6%
Asset Turnover0.39
6)

Structure

Current Ratio0.99
Quick Ratio0.49
Debt/Assets16.8%
Debt/Com Eq31.3%
Net Debt/EBITDA1.00
Tot Debt/Capital23.8%
Gross Margin72.8%
EBIT/Int Exp13.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years. This company reports in a different currency from the one its shares trade in, so any ratio dividing a market value by a statement figure crosses that boundary un-converted.